APA (7th ed.) Citation

E, G., M, C., L, R., I, P., S, D., S, H., . . . MB, C. (2012). Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang. British journal of haematology, 158(2), 186. https://doi.org/10.1111/j.1365-2141.2012.09161.x

Chicago Style (17th ed.) Citation

E, Gimenez, et al. "Cloned IGH VDJ Targets as Tools for Personalized Minimal Residual Disease Monitoring in Mature Lymphoid Malignancies; a Feasibility Study in Mantle Cell Lymphoma by the Groupe Ouest Est D'Etude Des Leucémies Et Autres Maladies Du Sang." British Journal of Haematology 158, no. 2 (2012): 186. https://doi.org/10.1111/j.1365-2141.2012.09161.x.

MLA (9th ed.) Citation

E, Gimenez, et al. "Cloned IGH VDJ Targets as Tools for Personalized Minimal Residual Disease Monitoring in Mature Lymphoid Malignancies; a Feasibility Study in Mantle Cell Lymphoma by the Groupe Ouest Est D'Etude Des Leucémies Et Autres Maladies Du Sang." British Journal of Haematology, vol. 158, no. 2, 2012, p. 186, https://doi.org/10.1111/j.1365-2141.2012.09161.x.